Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Efficacy Summary Hengruis Phase 3 trial enrolled 567 participants with a mean baseline body weight of 93 kg (205 lb) and evaluated HRS9531 doses of 2 mg, 4 mg, and 6 mg compared to placebo
The reduction in calorie intake leads to weight loss which is generally substantial in the first few months
Other person(s) from the same household participating in any semaglutide trial
Developed with the explicit goal of retaining GHRP-6's GH-releasing capability while eliminating its hormonal noise, it delivers on that promise with a selectivity profile that no other GHRP can match
US$ 21.80
US$ 28.67
US$ 26.36
US$ 27.74
